Last reviewed · How we verify
radiochemotherapy,combination Cetuximab-FOLFOX
radiochemotherapy,combination Cetuximab-FOLFOX is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development. Also known as: objective response rate,combination Cetuximab-FOLFOX.
At a glance
| Generic name | radiochemotherapy,combination Cetuximab-FOLFOX |
|---|---|
| Also known as | objective response rate,combination Cetuximab-FOLFOX |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery (PHASE2)
- FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- radiochemotherapy,combination Cetuximab-FOLFOX CI brief — competitive landscape report
- radiochemotherapy,combination Cetuximab-FOLFOX updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about radiochemotherapy,combination Cetuximab-FOLFOX
What is radiochemotherapy,combination Cetuximab-FOLFOX?
radiochemotherapy,combination Cetuximab-FOLFOX is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris.
Who makes radiochemotherapy,combination Cetuximab-FOLFOX?
radiochemotherapy,combination Cetuximab-FOLFOX is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).
Is radiochemotherapy,combination Cetuximab-FOLFOX also known as anything else?
radiochemotherapy,combination Cetuximab-FOLFOX is also known as objective response rate,combination Cetuximab-FOLFOX.
What development phase is radiochemotherapy,combination Cetuximab-FOLFOX in?
radiochemotherapy,combination Cetuximab-FOLFOX is in Phase 2.
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Also known as: objective response rate,combination Cetuximab-FOLFOX